Fortem Financial Group’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-7,994
Closed -$265K 174
2023
Q1
$265K Sell
7,994
-75,345
-90% -$2.62M 0.17% 125
2022
Q4
$2.8M Sell
83,339
-10,504
-11% -$354K 1.64% 11
2022
Q3
$3.23M Buy
93,843
+3,082
+3% +$112K 2.23% 6
2022
Q2
$2.93M Buy
90,761
+62,910
+226% +$2.1M 1.91% 7
2022
Q1
$1.1M Buy
27,851
+17,283
+164% +$683K 0.48% 83
2021
Q4
$500K Sell
10,568
-2,282
-18% -$118K 0.23% 116
2021
Q3
$702K Buy
12,850
+1,714
+15% +$96.9K 0.36% 95
2021
Q2
$678K Buy
11,136
+1,220
+12% +$69.9K 0.34% 95
2021
Q1
$574K Buy
+9,916
New +$620K 0.33% 93

Other funds holding BTEC

Fortem Financial Group's BTEC Position: Q2 2023 in Review

Fortem Financial Group sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q2 2023, closing a stake of 7,994 shares — an estimated $265K sold.

Fortem Financial Group first reported a position in BTEC in Q1 2021 and held it in 9 quarters. The position peaked at $3.23M in Q3 2022. 26 funds tracked by Wall St. Rank hold BTEC as of Q2 2023.

  • Fortem Financial Group reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q2 2023 after selling out during the quarter.
  • Fortem Financial Group sold 7,994 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q2 2023, an estimated $265K.
  • Fortem Financial Group first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q1 2021 and held it in 9 quarters.
  • Fortem Financial Group's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $3.23M in Q3 2022.
  • 26 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q2 2023.

Based on Fortem Financial Group's 13F filing for Q2 2023, filed 18 Jul 2023.